Orthofix Medical Inc. Deferred Federal Income Tax Expense (Benefit)
Orthofix Medical Inc. (OFIX) reported Deferred Federal Income Tax Expense (Benefit) of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-08-05
- Orthofix Medical Inc. deferred federal income tax expense (benefit) for the quarter ending 2026-06-30 was $0.00.
- Orthofix Medical Inc. deferred federal income tax expense (benefit) for the quarter ending 2026-03-31 was $0.00.
- Orthofix Medical Inc. deferred federal income tax expense (benefit) for fiscal 2025 was $639.00K, a 52.84% decline from fiscal 2024.
- Orthofix Medical Inc. deferred federal income tax expense (benefit) for fiscal 2024 was $1.35M, a 34.42% increase from fiscal 2023.
- Orthofix Medical Inc. deferred federal income tax expense (benefit) for fiscal 2023 was $1.01M, a 1404.48% increase from fiscal 2022.
- Orthofix Medical Inc. deferred federal income tax expense (benefit) for fiscal 2022 was $67.00K, a 99.72% decline from fiscal 2021.
| Period end | Deferred Federal Income Tax Expense (Benefit) 3 month | Deferred Federal Income Tax Expense (Benefit) 6 month | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | $639.00K 10-K · filed 2026-02-24 | |||
| 2024-12-31 | $1.35M 10-K · filed 2026-02-24 | $1.57M 10-K · filed 2025-02-25 | ||
| 2023-12-31 | $1.01M 10-K · filed 2026-02-24 | $1.16M 10-K · filed 2024-03-05 | ||
| 2022-12-31 | $67.00K 10-K · filed 2025-02-25 | |||
| 2021-12-31 | $24.29M 10-K · filed 2024-03-05 | |||
| 2020-12-31 | -$29.00K 10-K · filed 2023-03-06 | |||
| 2019-12-31 | $2.01M 10-K · filed 2022-02-25 | |||
| 2018-12-31 | -$3.43M 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $20.22M 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $9.30M 10-K · filed 2019-02-25 | |||
| 2015-12-31 | -$1.15M 10-K · filed 2018-02-26 | |||
| 2014-12-31 | $2.83M 10-K · filed 2017-02-27 | |||
| 2013-12-31 | $4.01M 10-K · filed 2016-02-29 | $5.72M 10-K · filed 2014-03-31 | ||
| 2012-12-31 | $2.67M 10-K · filed 2015-04-29 | -$503.00K 10-K · filed 2013-03-01 | ||
| 2011-12-31 | -$13.24M 10-K/A · filed 2015-03-31 | -$169.00K 10-K · filed 2012-02-29 | ||
| 2010-12-31 | $2.28M 10-K/A · filed 2014-03-24 | -$1.53M 10-K · filed 2012-02-29 | ||
| 2009-12-31 | -$6.70M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |